187 related articles for article (PubMed ID: 15727557)
21. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2002; (4):CD003895. PubMed ID: 12519614
[TBL] [Abstract][Full Text] [Related]
22. In vivo evidence that erythropoietin protects neurons from ischemic damage.
Sakanaka M; Wen TC; Matsuda S; Masuda S; Morishita E; Nagao M; Sasaki R
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4635-40. PubMed ID: 9539790
[TBL] [Abstract][Full Text] [Related]
23. Neuroprotective role of erythropoietin in neonates.
Juul S
J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 4():105-7. PubMed ID: 22958035
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory cytokine tumor necrosis factor α suppresses neuroprotective endogenous erythropoietin from astrocytes mediated by hypoxia-inducible factor-2α.
Nagaya Y; Aoyama M; Tamura T; Kakita H; Kato S; Hida H; Saitoh S; Asai K
Eur J Neurosci; 2014 Dec; 40(11):3620-6. PubMed ID: 25283246
[TBL] [Abstract][Full Text] [Related]
25. [Erythropoietin--a new therapy in cerebral ischemia?].
Kalialis LV; Olsen NV
Ugeskr Laeger; 2003 Jun; 165(24):2477-81. PubMed ID: 12872467
[TBL] [Abstract][Full Text] [Related]
26. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.
Maurice T; Mustafa MH; Desrumaux C; Keller E; Naert G; de la C García-Barceló M; Rodríguez Cruz Y; Garcia Rodríguez JC
J Psychopharmacol; 2013 Nov; 27(11):1044-57. PubMed ID: 23813967
[TBL] [Abstract][Full Text] [Related]
27. Midazolam inhibits the hypoxia-induced up-regulation of erythropoietin in the central nervous system.
Matsuyama T; Tanaka T; Tatsumi K; Daijo H; Kai S; Harada H; Fukuda K
Eur J Pharmacol; 2015 Aug; 761():189-98. PubMed ID: 26001375
[TBL] [Abstract][Full Text] [Related]
28. Erythropoietin and erythropoietin receptor expression after experimental spinal cord injury encourages therapy by exogenous erythropoietin.
Grasso G; Sfacteria A; Passalacqua M; Morabito A; Buemi M; Macrì B; Brines ML; Tomasello F
Neurosurgery; 2005 Apr; 56(4):821-7; discussion 821-7. PubMed ID: 15792521
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic strategy of erythropoietin in neurological disorders.
Liu XB; Wang JA; Yu SP; Keogh CL; Wei L
CNS Neurol Disord Drug Targets; 2008 Jun; 7(3):227-34. PubMed ID: 18673207
[TBL] [Abstract][Full Text] [Related]
30. Brain and cancer: the protective role of erythropoietin.
Buemi M; Caccamo C; Nostro L; Cavallaro E; Floccari F; Grasso G
Med Res Rev; 2005 Mar; 25(2):245-59. PubMed ID: 15389732
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin regulates hypoxic ventilation in mice by interacting with brainstem and carotid bodies.
Soliz J; Joseph V; Soulage C; Becskei C; Vogel J; Pequignot JM; Ogunshola O; Gassmann M
J Physiol; 2005 Oct; 568(Pt 2):559-71. PubMed ID: 16051624
[TBL] [Abstract][Full Text] [Related]
32. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
[TBL] [Abstract][Full Text] [Related]
33. [Erythropoietin--physiology and therapeutic potentialities].
Möllmann M
Anasthesiol Intensivmed Notfallmed Schmerzther; 1992 Dec; 27(8):461-8. PubMed ID: 1489869
[TBL] [Abstract][Full Text] [Related]
34. Selective inhibition of nitric oxide in hypoxic-ischemic brain model in newborn rats: is it an explanation for the protective role of erythropoietin?
Kumral A; Baskin H; Gokmen N; Yilmaz O; Genc K; Genc S; Tatli MM; Duman N; Ozer E; Ozkan H
Biol Neonate; 2004; 85(1):51-4. PubMed ID: 14631167
[TBL] [Abstract][Full Text] [Related]
35. Brain protection by erythropoietin: a manifold task.
Rabie T; Marti HH
Physiology (Bethesda); 2008 Oct; 23():263-74. PubMed ID: 18927202
[TBL] [Abstract][Full Text] [Related]
36. Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin.
Zakharova ET; Sokolov AV; Pavlichenko NN; Kostevich VA; Abdurasulova IN; Chechushkov AV; Voynova IV; Elizarova AY; Kolmakov NN; Bass MG; Semak IV; Budevich AI; Kozhin PM; Zenkov NK; Klimenko VM; Kirik OV; Korzhevskii DE; Menshchikova EB; Vasilyev VB
Biometals; 2018 Jun; 31(3):425-443. PubMed ID: 29748743
[TBL] [Abstract][Full Text] [Related]
37. Treating anemia associated with chronic renal failure with erythropoiesis stimulators: recombinant human erythropoietin might be the best among the available choices.
Trkulja V
Med Hypotheses; 2012 Jan; 78(1):157-61. PubMed ID: 22078846
[TBL] [Abstract][Full Text] [Related]
38. Activation of migration of endogenous stem cells by erythropoietin as potential rescue for neurodegenerative diseases.
Khairallah MI; Kassem LA; Yassin NA; Gamal el Din MA; Zekri M; Attia M
Brain Res Bull; 2016 Mar; 121():148-57. PubMed ID: 26802509
[TBL] [Abstract][Full Text] [Related]
39. Beneficial and ominous aspects of the pleiotropic action of erythropoietin.
Jelkmann W; Wagner K
Ann Hematol; 2004 Nov; 83(11):673-86. PubMed ID: 15322761
[TBL] [Abstract][Full Text] [Related]
40. [Hematopoietic growth factor EPO has neuro-protective and neuro-trophic effects--review].
Zhou ZY; Yang M; Fok TF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):332-7. PubMed ID: 15854305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
